ImmPACT Bio to Present at the 2023 Jefferies Healthcare Conference
WEST HILLS, Calif., May 23, 2023 /PRNewswire/ — ImmPACT Bio USA, Inc. (“ImmPACT BIO”), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune diseases, today announced that it will participate at the 2023 Jefferies Healthcare Conference, to be held from June 7-9, 2023, in New York, NY. … Read more